搜尋結果
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 6 日前A Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that ...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval ...
CNBC· 6 日前Eli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzhei ...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 5 日前Eli Lilly became the most valuable health-care company in the world on the back of its ...
Why Aging Parents With Memory Loss Must Stop Managing Money
Forbes· 4 日前A new study published in the New York Times demonstrates some startling findings about loss of ability to make money decisions ...
US FDA advisers to review Eli Lilly Alzheimer's drug
Reuters· 6 日前Both drugs are designed to remove toxic beta amyloid plaques from the brains of people with ear ...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know ...
Forbes· 7 日前... of experts advising the Food and Drug Administration could on Monday recommend Eli Lilly’s ...
FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug
Forbes· 7 日前A Food and Drug Administration advisory panel unanimously voted Monday to recommend Eli Lilly’s ...
About 4% of US adults age 65 and older have a dementia diagnosis, survey finds
Reuters· 4 日前Some 4% of U.S. adults aged 65 and older say they have been diagnosed with dementia ...
A New Drug Could Slow Alzheimer's. But Can Patients Get It?
Bloomberg· 4 日前A New Drug Could Slow Alzheimer's. But Can Patients Get It? A new medicine from Eli ... ...
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 5 日前Around 25 million Americans are affected by the eye disease Demodex blepharitis, which is ...